1. Vitale, Silvia R, Ruigrok-Ritstier, Kirsten, Timmermans, A Mieke, Sieuwerts, Anieta M, Jansen, Maurice P H M. 2022. The prognostic and predictive value of ESR1 fusion gene transcripts in primary breast cancer. In BMC cancer, 22, 165. doi:10.1186/s12885-022-09265-1. https://pubmed.ncbi.nlm.nih.gov/35151276/
2. Perry, J Jefferson P, Ballard, Gregory D, Albert, Alexandra E, Malkas, Linda H, Hoelz, Derek J. 2015. Human C6orf211 encodes Armt1, a protein carboxyl methyltransferase that targets PCNA and is linked to the DNA damage response. In Cell reports, 10, 1288-96. doi:10.1016/j.celrep.2015.01.054. https://pubmed.ncbi.nlm.nih.gov/25732820/
3. Dennis, Taylor N, Kenjić, Nikola, Kang, Amrik S, Clarke, Steven G, Perry, J Jefferson P. 2020. Human ARMT1 structure and substrate specificity indicates that it is a DUF89 family damage-control phosphatase. In Journal of structural biology, 212, 107576. doi:10.1016/j.jsb.2020.107576. https://pubmed.ncbi.nlm.nih.gov/32682077/
4. Lung, David K, Warrick, Jay W, Hematti, Peiman, Miyamoto, Shigeki, Alarid, Elaine T. . Bone Marrow Stromal Cells Transcriptionally Repress ESR1 but Cannot Overcome Constitutive ESR1 Mutant Activity. In Endocrinology, 160, 2427-2440. doi:10.1210/en.2019-00299. https://pubmed.ncbi.nlm.nih.gov/31504407/
5. Nonomura, Chizu, Otsuka, Masaki, Kondou, Ryota, Yamaguchi, Ken, Akiyama, Yasuto. 2019. Identification of a neoantigen epitope in a melanoma patient with good response to anti-PD-1 antibody therapy. In Immunology letters, 208, 52-59. doi:10.1016/j.imlet.2019.02.004. https://pubmed.ncbi.nlm.nih.gov/30880120/
智鼠故事 
